11
Mar
2010
Posted in I - Series A, Q - 1Q10, R - NORTH EAST, X - Migraine, X - Neurology, X - Pain, XX - NJ
Nautilus Neurosciences (Bridgewater, NJ) near commercial-stage specialty neurology pharma focused on migraine and acute pain, closed a $14.5M Series A financing. Participants include Tailwind Capital.
_________________________________________________________________________
NOTE: New OnBioVC Friday feature coming, well…this Friday!
04
Feb
2010
Posted in I - Series A, Q - 4Q09, R - WEST, X - Pain, XX - CA
Afferent Pharmaceuticals (Palo Alto, CA) a clinical-stage biopharmaceutical company focused on pain associated with conditions such as osteoarthritis, back pain, visceral pain and neuropathy, closed a $23M Series A financing. Participants include Third Rock Ventures, Pappas Ventures, Domain Associates and New Leaf Venture Partners.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb
31
Jan
2010
Posted in I - Series C, Q - 4Q09, R - INTERNATIONAL, X - Analgesic, X - Pain
SantoSolve (Norway) a clinical-stage biopharmaceutical company focused on topical analgesic products based on non-radioactive strontium for various pain conditions, closed a $5.5M Series C financing. Participants include Teknoinvest, InnovationsKapital and Investinor.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb
30
Oct
2009
Posted in I - Series B, Q - 3Q09, R - WEST, X - Device (Delivery), X - Drug:Device Combo, X - Pain, XX - CA
Zogenix (San Diego, CA) a clinical-stage drug:device company focused on a needle-free delivery system of chronic pain therapeutic, closed a $51M Series B financing. Participants include Clarus Ventures, Domain Associates, Scale Venture Partners, Thomas, McNerney & Partners, Oxford Finance and Abingworth Management.
20
Jul
2009
23
Jun
2009
Posted in I - Series D, Q - 2Q09, R - SOUTH EAST, X - Menorrhagia, X - Pain, XX - KY
Xanodyne Pharmaceuticals (Newport, KY) an clinical-stage specialty pharmaceutical company focused on pain and menorrhagia, closed a $38M Series D financing. Participants include MPM Capital, AIG Investments, Aisling Capital, Blue Chip Venture Company, Essex Woodlands Health Ventures, HealthCare Ventures and Union Springs Pharmaceuticals.
26
Apr
2009
30
Mar
2009
Posted in I - Series B, Q - 1Q09, R - SOUTH EAST, X - Epilepsy, X - Pain, X - Seizures, XX - KY
Ikano Therapeutics (Lexington, KY) a clinical-stage nasal delivery platform company focused on seizures and pain, closed a $9M Series B financing, the final tranche of a $18M round. Participants include SV Life Sciences, Burrill & Co., Tullis-Dickerson, Fidelity Biosciences, Apjohn Ventures, Fort Washington Capital, Commonwealth Seed Capital and Kentucky Co-Investment Partners.
19
Jan
2009
Posted in I - Series D, Q - 1Q09, R - NORTH EAST, X - Inflammation, X - Pain, XX - MA
Hydra Biosciences (Cambridge, MA) a pre-clinical stage developer of therapeutics for pain, inflammation and cardiovascular disease, closed a $22M Series D financing. Participants include MedImmune Ventures, Advanced Technology Ventures, Abingworth, Polaris Venture Partners, BioVenture Investors, Biogen Idec Ventures and Lilly Ventures.
01
Dec
2008